We are happy to share our last flyer for our conference #YS2C_GSO. Join us at #Toulouse. This day is a great opportunity to catch up on the latest #cancer #research discoveries and expand your network. The oral abstract deadline is July 13th. #biology #ClinicalResearch RT please

Thank you Justin Milner & Brandon Pratt for highlighting our work in Science Magazine science.org/doi/10.1126/sc…

Bravo AYYOUB LAB Devaud Christel Virginie Feliu pour cette découverte publiée dans Science Immunology

Cancer : le superpouvoir du côlon pour lutter contre les métastases, une découverte toulousaine majeure ladepeche.fr/2023/06/10/can… via La Dépêche du Midi

🚨🔥Hot off the press🔥 Our study on the impact of radiation to host immune structures during chemoradiation > durva in patients with st.III non small cell lung cancer is out in Frontiers - Oncology #nsclc 🫁⚡️ 🧵 1/5 frontiersin.org/articles/10.33…

Congratulations Jonathan Khalifa 🎗️ Julien Mazieres Cosimo Pasqualino & team

Read the interview of Devaud Christel & Virginie Feliu in ACIR highlighting their findings published in Science Immunology It's about tumor immunology & more 🤔 acir.org/weekly-digests…

[CRCT press release] Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team. Article published in the journal Immunity by the GENIM team at CRCT-Oncopole ➡️crct-inserm.fr/en/cancer-a-ke…

Did you ever wonder what RNA rings, so-called circular RNAs (#circRNAs) have to do with the childhood cancer #neuroblastoma? Actually, more than you might think. Check out our recent publication in Nature Communications, I'm excited to share it with you! 1/14

Thank you Cancer Discovery for the research watch about our works, Devaud Christel AYYOUB LAB IUCT Oncopole CRCT-Oncopole α4β7-Positive T Cells Mediate Responses to Cancer Immunotherapy …rnals-org.proxy.insermbiblio.inist.fr/cancerdiscover…

#Postdoctoral fellow at the #Cancer Research Center, Toulouse, France on the impact of combining #TNF blockade and #immunotherapy on #immune responses and #melanoma liver metastases in #mice. 2 year contract from Nov 1, 2023 Contact [email protected] before October 15, 2023.

Des chercheuses révèlent comment notre côlon lutte contre le cancer colorectal : vers des thérapies ciblées et un potentiel vaccin france3-regions.francetvinfo.fr/occitanie/haut… Devaud Christel AYYOUB LAB IUCT Oncopole CRCT-Oncopole

Sarry Lab Save the Date: Mini-Symposium "Heterogeneity, Evolution and Drug Resistance in Cancer" with MarineLab from @VIB and Hugues de Thé from Collège de France on 12/18 at 10am @Oncopole

SOUTENEZ Romina D'Angelo de l'équipe Guillermet's Lab du CRCT-Oncopole qui fait partie des finalistes du concours CNRS "La preuve par l'image" pour son image "Beauté fatale" Pour voter c'est ici concours-preuve-image.fr/vote-du-public/

The IUCT-Oncopole is honoured and delighted to welcome Ira Mellman, Vice President of Genentech Dr Mellman will be giving a lecture in person at Oncopole on the theme: "Mechanics basis of cancer immunotherapy". 📆Friday 2 February 🕘11h00-12h00 📍IUCT-Oncopole in Toulouse

Amphithéâtre comble pour la venue d'Ira Mellman CRCT-Oncopole AYYOUB LAB

Congratulations Alejandra. Alejandra is leading basic and translational research within our team in ovarian cancer with Anna Salvioni & Clara Scarlata and in cervical cancer with Giulia Costanza Leonardi CRCT-Oncopole IUCT Oncopole ESGO

🚨Postdoc position announcement!!! Please share and RT.🚨 The Scipioni Lab is seeking a highly motivated and skilled postdoctoral researcher to work on cutting-edge projects involving the design, development, and implementation of advanced microscopes (see below) 1/4

Thrilled to announce that Institut national du cancer has awarded a 5 yr label to the COALA (Cure Oncogene Addicted Lung Adenocarcinoma) network that gathers 15 research teams in France. Looking forward to starting the program and improving patients outcome. CHU de Toulouse - compte inactif CRCT-Oncopole